AIM: To determine whether the European Consensus Lupus Activity Measurement Index (ECLAM) can be used to evaluate disease activity in patients retrospectively from the data provided in their clinical charts. METHODS: The ECLAM score was calculated twice in a series of 64 consecutive SLE patients: first for each patient during the course of a standard clinical evaluation (direct-ECLAM), and then one to two weeks later solely on the basis of the data provided in the patient's clinical chart (chartECLAM). The scorings for each patient were performed by two different assessors. RESULTS: The direct-ECLAM and chart-ECLAM scores were highly correlated (Spearman's rank correlation coefficient = 0.86). The regression line was not significantly different from the identity line (t-test). The Pearson's coefficient was 0.88. The interobserver variability of the chart-ECLAM showed a low inter-rater variability. CONCLUSION: ECLAM could represent a valid and reliable instrument for the retrospective analysis of disease activity in SLE patients.
AIM: To determine whether the European Consensus Lupus Activity Measurement Index (ECLAM) can be used to evaluate disease activity in patients retrospectively from the data provided in their clinical charts. METHODS: The ECLAM score was calculated twice in a series of 64 consecutive SLEpatients: first for each patient during the course of a standard clinical evaluation (direct-ECLAM), and then one to two weeks later solely on the basis of the data provided in the patient's clinical chart (chartECLAM). The scorings for each patient were performed by two different assessors. RESULTS: The direct-ECLAM and chart-ECLAM scores were highly correlated (Spearman's rank correlation coefficient = 0.86). The regression line was not significantly different from the identity line (t-test). The Pearson's coefficient was 0.88. The interobserver variability of the chart-ECLAM showed a low inter-rater variability. CONCLUSION: ECLAM could represent a valid and reliable instrument for the retrospective analysis of disease activity in SLEpatients.
Authors: Raffaello Bonacchi; Maria A Rocca; Giuseppe A Ramirez; Enrica P Bozzolo; Valentina Canti; Paolo Preziosa; Paola Valsasina; Gianna C Riccitelli; Alessandro Meani; Lucia Moiola; Patrizia Rovere-Querini; Angelo A Manfredi; Massimo Filippi Journal: Mol Psychiatry Date: 2020-10-13 Impact factor: 15.992